Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC
NCT02999646
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
OTHER:
MVX-ONCO-1
Sponsor
Maxivax SA
Collaborators
[object Object]